Literature DB >> 30554786

Fibroblast growth factor 21 for non-alcoholic steatohepatitis.

Vincent W S Wong1, Leon A Adams2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30554786     DOI： 10.1016/S0140-6736(18)32165-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The Role of H2S in the Metabolism of Glucose and Lipids.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Xiao-Wei Nie; Jin-Song Bian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.

Authors:  Katsutoshi Tokushige; Kenichi Ikejima; Masafumi Ono; Yuichiro Eguchi; Yoshihiro Kamada; Yoshito Itoh; Norio Akuta; Masato Yoneda; Motoh Iwasa; Masashi Yoneda; Motoyuki Otsuka; Nobuharu Tamaki; Tomomi Kogiso; Hiroto Miwa; Kazuaki Chayama; Nobuyuki Enomoto; Tooru Shimosegawa; Tetsuo Takehara; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-09-17       Impact factor: 7.527

3.  Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.

Authors:  Xinyue Li; Xiaojuan Wu; Yumei Jia; Jing Fu; Lin Zhang; Tao Jiang; Jia Liu; Guang Wang
Journal:  J Diabetes Res       Date:  2021-10-08       Impact factor: 4.011

4.  FGF21 induces autophagy-mediated cholesterol efflux to inhibit atherogenesis via RACK1 up-regulation.

Authors:  Lin Xiaolong; Guo Dongmin; Mihua Liu; Wang Zuo; Hu Huijun; Tan Qiufen; Hu XueMei; Lin Wensheng; Pan Yuping; Lin Jun; Zeng Zhaolin
Journal:  J Cell Mol Med       Date:  2020-03-30       Impact factor: 5.310

5.  Tsukushi and TSKU genotype in obesity and related metabolic disorders.

Authors:  Y Li; L Jin; J Yan; Y Huang; H Zhang; R Zhang; C Hu
Journal:  J Endocrinol Invest       Date:  2021-04-15       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.